JY
LEGN icon

Jeff Yass’s Legend Biotech LEGN Stock Holding History

Jeff Yass’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
35,348
-147,016
-81% -$3.97M ﹤0.01% 8143
2026
Q1 		$3.3M Buy
182,364
+29,089
+19% +$555K ﹤0.01% 5072
2025
Q4 		$3.33M Sell
153,275
-74,233
-33% -$2.13M ﹤0.01% 4690
2025
Q3 		$7.42M Sell
227,508
-18,638
-8% -$688K ﹤0.01% 3460
2025
Q2 		$8.74M Buy
246,146
+146,947
+148% +$4.76M ﹤0.01% 3016
2025
Q1 		$3.37M Buy
99,199
+15,760
+19% +$565K ﹤0.01% 4417
2024
Q4 		$2.72M Buy
83,439
+30,008
+56% +$1.24M ﹤0.01% 4661
2024
Q3 		$2.6M Sell
53,431
-5,642
-10% -$301K ﹤0.01% 4799
2024
Q2 		$2.62M Buy
+59,073
New +$2.73M ﹤0.01% 4569
2024
Q1 		– Sell
-33,709
Closed -$2.03M – 12816
2023
Q4 		$2.03M Buy
33,709
+20,135
+148% +$1.28M ﹤0.01% 5321
2023
Q3 		$912K Buy
13,574
+5,748
+73% +$399K ﹤0.01% 6833
2023
Q2 		$540K Buy
+7,826
New +$511K ﹤0.01% 8129
2023
Q1 		– Sell
-55,532
Closed -$2.72M – 13091
2022
Q4 		$2.77M Buy
+55,532
New +$2.69M ﹤0.01% 4139
2022
Q2 		– Sell
-25,930
Closed -$1.09M – 13482
2022
Q1 		$942K Sell
25,930
-6,717
-21% -$265K ﹤0.01% 7282
2021
Q4 		$1.52M Buy
+32,647
New +$1.66M ﹤0.01% 6173
2021
Q3 		– Sell
-56,309
Closed -$2.34M – 13197
2021
Q2 		$2.31M Buy
56,309
+48,823
+652% +$1.66M ﹤0.01% 5598
2021
Q1 		$217K Buy
+7,486
New +$204K ﹤0.01% 11265

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Jeff Yass's LEGN Position: Q2 2026 in Review

Jeff Yass reduced its Legend Biotech (LEGN) stake by 81% in Q2 2026, selling an estimated $3.97M and leaving 35,348 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #8143.

Jeff Yass first reported a position in LEGN in Q1 2021 and has held it in 17 quarters since. The position peaked at $8.74M in Q2 2025. 217 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Jeff Yass held 35,348 shares of Legend Biotech worth $1.02M as of Q2 2026.
  • Jeff Yass sold 147,016 Legend Biotech shares in Q2 2026, an estimated $3.97M.
  • Legend Biotech made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8143 holding.
  • Jeff Yass first reported a position in Legend Biotech in Q1 2021 and has held it in 17 quarters since.
  • Jeff Yass's Legend Biotech position peaked at $8.74M in Q2 2025.
  • 217 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.